Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

Despite medical advancements, HIV remains a serious public health issue in the United States, with about 30,000 new diagnoses reported each year, according to federal data. Dr. Andrew See, a ...

Knowing how to leverage these technologies means we can help set the new standard and inform the next evolution of HIV care.

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

Here are three things to know. 1. Trogarzo is an antiretroviral medication for adult patients with HIV who do not respond to other HIV therapies on the market. 2. Clinicians administer the intravenous ...

Purpose: The pharmacology, efficacy, and safety of etravirine and its clinical utility with respect to the available alternative human immunodeficiency virus (HIV) treatment options are reviewed.

Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences is conducting a Phase 2/3 open-label study titled ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced its program for the upcoming 25th International AIDS Conference (AIDS 2024), taking place in Munich, Germany, ...

The Center for Women's Reproductive Care at Columbia University (CWRC; NY, USA) has been at the forefront of innovative therapy for HIV-serodiscordant couples in the USA. Appreciative of the CDC ...